Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
5,111,468
-
Shares change
-
+3,120,815
-
Total reported value, excl. options
-
$30,566,000
-
Value change
-
+$18,924,636
-
Put/Call ratio
-
72.5%
-
Number of buys
-
9
-
Number of sells
-
-6
-
Price
-
$5.98
Significant Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q2 2021
23 filings reported holding ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share as of Q2 2021.
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,111,468 shares
of 45,504,462 outstanding shares and own 11.23% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (2,484,275 shares), RA CAPITAL MANAGEMENT, L.P. (2,353,000 shares), CITADEL ADVISORS LLC (67,170 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (66,733 shares), MILLENNIUM MANAGEMENT LLC (34,775 shares), Verition Fund Management LLC (30,523 shares), GEODE CAPITAL MANAGEMENT, LLC (17,597 shares), SIMPLEX TRADING, LLC (15,742 shares), SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (14,400 shares), and XTX Topco Ltd (10,433 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.